Crestwood Advisors Group LLC Sells 12,970 Shares of Danaher Corporation $DHR

Crestwood Advisors Group LLC decreased its position in Danaher Corporation (NYSE:DHR) by 3.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 316,651 shares of the conglomerate’s stock after selling 12,970 shares during the quarter. Danaher accounts for approximately 1.1% of Crestwood Advisors Group LLC’s holdings, making the stock its 26th largest holding. Crestwood Advisors Group LLC’s holdings in Danaher were worth $62,777,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Sivia Capital Partners LLC grew its position in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares in the last quarter. Koshinski Asset Management Inc. boosted its stake in shares of Danaher by 17.5% during the 2nd quarter. Koshinski Asset Management Inc. now owns 2,042 shares of the conglomerate’s stock worth $403,000 after buying an additional 304 shares during the last quarter. Chicago Partners Investment Group LLC grew its holdings in shares of Danaher by 2.4% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 10,900 shares of the conglomerate’s stock valued at $2,157,000 after acquiring an additional 256 shares in the last quarter. Salomon & Ludwin LLC increased its position in shares of Danaher by 58.1% in the second quarter. Salomon & Ludwin LLC now owns 449 shares of the conglomerate’s stock valued at $91,000 after acquiring an additional 165 shares during the last quarter. Finally, Cidel Asset Management Inc. raised its holdings in Danaher by 9.8% during the second quarter. Cidel Asset Management Inc. now owns 2,146 shares of the conglomerate’s stock worth $424,000 after acquiring an additional 191 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE DHR opened at $212.37 on Tuesday. The stock has a market cap of $150.01 billion, a PE ratio of 42.14, a P/E/G ratio of 2.87 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The firm has a 50-day moving average of $228.40 and a 200-day moving average of $215.71. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. During the same period in the prior year, the firm earned $2.14 EPS. The business’s revenue was up 4.6% on a year-over-year basis. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is currently 25.40%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Morgan Stanley started coverage on Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price target on the stock. Barclays boosted their target price on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Wells Fargo & Company increased their price target on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Leerink Partners boosted their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.